Characteristic | No. (%) of patients* n = 116 |
---|---|
Demographic | |
Age, mean ± SD, yr | 63 ± 13.1 |
Gender | |
Male | 76 (65.5) |
Female | 37 (31.9) |
Missing | 3 (2.6) |
Ethnicity | |
White | 77 (66.4) |
First Nations/Aboriginal | 6 (5.2) |
South American/Central American/Caribbean | 5 (4.3) |
Middle East | 1 (0.9) |
Asian | 15 (12.9) |
Missing | 12 (10.3) |
Symptom duration, wk | |
≤ 12 | 45 (38.8) |
13–24 | 23 (19.8) |
25–52 | 25 (21.6) |
> 52 | 7 (6.0) |
Missing | 16 (13.8) |
Weight loss, pounds | |
≤ 10 (4.5 kg) | 35 (30.2) |
11–25 (5.0–11.3 kg) | 20 (17.2) |
26–50 (11.8–22.7 kg) | 24 (20.7) |
> 50 (22.7 kg) | 2 (1.7) |
Missing | 35 (30.2) |
Preoperative imaging findings | |
Primary tumour visible | |
Yes | 93 (80.2) |
No | 18 (15.5) |
Equivocal | 3 (2.6) |
Missing | 2 (1.7) |
Intrathoracic metastases | |
Yes | 1 (0.9) |
No | 98 (84.5) |
Equivocal | 15 (12.9) |
Missing | 2 (1.7) |
Abdominal lymphadenopathy > 1 cm | 8 (6.9) |
Ascites | 8 (6.9) |
Peritoneal nodules | |
Yes | 1 (0.9) |
No | 112 (96.6) |
Missing | 3 (2.6) |
Omental nodules | 3 (2.6) |
Tumour characteristics | |
Location | |
Gastroesophageal junction | 34 (29.3) |
Upper stomach not involving gastroesophageal junction | 24 (20.7) |
Body of stomach | 27 (23.3) |
Antrum/pylorus | 29 (25.0) |
Entire stomach | 1 (0.9) |
Other | 1 (0.9) |
Biopsy pathologic findings | |
Adenocarcinoma not otherwise specified | 47 (40.5) |
Adenocarcinoma intestinal type | 11 (9.5) |
Adenocarcinoma diffuse type no signet cells | 3 (2.6) |
Adenocarcinoma with signet cells | 55 (47.4) |
Grade | |
Well-differentiated, low grade | 2 (1.7) |
Moderately differentiated, mid-grade | 6 (5.2) |
Poorly differentiated, high grade | 78 (67.2) |
Missing | 30 (25.9) |
SD = standard deviation.
↵* Except where noted otherwise.